Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
This acquisition marks Max Healthcare's entry into Lucknow
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
GMM Pfaudler US completes acquisition of MixPro
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Both the India and GCC entities will be operated by separate dedicated management teams
Subscribe To Our Newsletter & Stay Updated
